Lam Research (NASDAQ:LRCX – Free Report) had its price target raised by Citigroup from $265.00 to $300.00 in a research note released on Thursday,Benzinga reports. They currently have a buy rating on the semiconductor company’s stock.
Several other research firms also recently commented on LRCX. Evercore ISI set a $275.00 target price on shares of Lam Research in a research report on Thursday. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Lam Research in a research note on Monday, December 29th. Royal Bank Of Canada reissued an “outperform” rating and issued a $290.00 price objective (up previously from $260.00) on shares of Lam Research in a research note on Thursday. Dbs Bank increased their price objective on Lam Research from $119.40 to $184.20 in a report on Monday, October 27th. Finally, B. Riley reaffirmed a “buy” rating on shares of Lam Research in a research report on Thursday, January 15th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $238.32.
Read Our Latest Analysis on Lam Research
Lam Research Price Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the business earned $0.91 earnings per share. The company’s revenue for the quarter was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts predict that Lam Research will post 3.71 earnings per share for the current fiscal year.
Lam Research Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd were given a dividend of $0.26 per share. The ex-dividend date was Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. Lam Research’s dividend payout ratio is presently 21.31%.
Insider Activity at Lam Research
In other Lam Research news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 41,408 shares of company stock valued at $6,248,501 in the last ninety days. 0.31% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Lam Research
A number of institutional investors have recently modified their holdings of LRCX. PMV Capital Advisers LLC bought a new position in shares of Lam Research in the fourth quarter valued at $25,000. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the 2nd quarter worth about $26,000. Stance Capital LLC bought a new position in Lam Research in the 3rd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new position in Lam Research during the 2nd quarter valued at about $27,000. Finally, Triumph Capital Management acquired a new position in Lam Research during the 3rd quarter valued at about $27,000. 84.61% of the stock is owned by institutional investors and hedge funds.
More Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Multiple major brokers sharply raised targets (many to $275–$300), signaling broad analyst bullishness after the quarter and suggesting upside versus earlier prices. These Analysts Boost Their Forecasts On Lam Research Following Strong Q2 Results
- Positive Sentiment: JPMorgan and Citigroup raised targets to $300 (overweight/buy), and firms including Needham, TD Cowen, Wells Fargo, Deutsche and Stifel also lifted targets — a strong institutional vote of confidence for continued AI/foundry-driven demand. Analyst target increases (Benzinga)
- Positive Sentiment: Lam beat Q2 estimates (EPS $1.27 vs. $1.17 est.; revenue $5.34B vs. $5.23B) and issued Q3 EPS guidance of $1.25–$1.45 and revenue above consensus — concrete operational drivers behind analyst upgrades. Lam Research Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
- Neutral Sentiment: New Street Research raised its target to $235 but kept a neutral rating, reflecting near-term upside limited relative to recent price strength. New Street adjusts price target on Lam Research to $235
- Negative Sentiment: HSBC raised its target to $221 but maintained a “hold,” which implies downside from recent levels and highlights some analyst caution despite better results. HSBC adjusts price target on Lam Research to $221
- Negative Sentiment: Coverage notes flag valuation concerns after a large run (high P/E and steep analyst target dispersion), which may limit further upside and explains some profit‑taking. Lam Research Earnings Beat Highlights AI Demand But Raises Valuation Questions
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
- Five stocks we like better than Lam Research
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Become a 2x better options trader (in 2 days)
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
